These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2231339)
1. Radioimmunoassay of a new angiotensin-converting enzyme inhibitor (perindopril) in human plasma and urine: advantages of coupling anion-exchange column chromatography with radioimmunoassay. Doucet L; De Veyrac B; Delaage M; Cailla H; Bernheim C; Devissaguet M J Pharm Sci; 1990 Aug; 79(8):741-5. PubMed ID: 2231339 [TBL] [Abstract][Full Text] [Related]
2. A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor perindopril and its active metabolite in plasma and urine: advantages of a lysine derivative as immunogen to improve the assay specificity. van den Berg H; Resplandy G; de Bie AT; Floor W; Bertrand M; Arts CJ J Pharm Biomed Anal; 1991; 9(7):517-24. PubMed ID: 1817672 [TBL] [Abstract][Full Text] [Related]
3. Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects. Louis WJ; Workman BS; Conway EL; Worland P; Rowley K; Drummer O; McNeil JJ; Harris G; Jarrott B J Cardiovasc Pharmacol; 1992 Sep; 20(3):505-11. PubMed ID: 1279299 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine. Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of perindopril and its metabolites in healthy volunteers. Devissaguet JP; Ammoury N; Devissaguet M; Perret L Fundam Clin Pharmacol; 1990; 4(2):175-89. PubMed ID: 2351367 [TBL] [Abstract][Full Text] [Related]
6. Influence of food on the pharmacokinetics of perindopril and the time course of angiotensin-converting enzyme inhibition in serum. Lecocq B; Funck-Brentano C; Lecocq V; Ferry A; Gardin ME; Devissaguet M; Jaillon P Clin Pharmacol Ther; 1990 Mar; 47(3):397-402. PubMed ID: 2311339 [TBL] [Abstract][Full Text] [Related]
7. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency. Verpooten GA; Genissel PM; Thomas JR; De Broe ME Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092 [TBL] [Abstract][Full Text] [Related]
8. Perindopril. A review of its pharmacokinetics and clinical pharmacology. Macfadyen RJ; Lees KR; Reid JL Drugs; 1990; 39 Suppl 1():49-63. PubMed ID: 2407493 [TBL] [Abstract][Full Text] [Related]
9. First LC-MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence study. Jain DS; Subbaiah G; Sanyal M; Pande UC; Shrivastav P J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):92-100. PubMed ID: 16709467 [TBL] [Abstract][Full Text] [Related]
10. Interspecies comparison of the metabolic pathways of perindopril, a new angiotensin-converting enzyme (ACE) inhibitor. Grislain L; Mocquard MT; Dabe JF; Bertrand M; Luijten W; Marchand B; Resplandy G; Devissaguet M Xenobiotica; 1990 Aug; 20(8):787-800. PubMed ID: 2219962 [TBL] [Abstract][Full Text] [Related]
12. A new LC-MS/MS bioanalytical method for perindopril and perindoprilat in human plasma and milk. Lwin EMP; Gerber C; Song Y; Leggett C; Ritchie U; Turner S; Garg S Anal Bioanal Chem; 2017 Oct; 409(26):6141-6148. PubMed ID: 28842738 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis. Tsai HH; Lees KR; Howden CW; Reid JL Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045 [TBL] [Abstract][Full Text] [Related]
14. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite, zabiciprilat, in human plasma. Lelievre E; Cardona H; Brillanceau MH; Piraube C; Sauveur C J Pharm Sci; 1992 Nov; 81(11):1065-70. PubMed ID: 1447705 [TBL] [Abstract][Full Text] [Related]
16. Hydrophilic interaction liquid chromatography/positive ion electrospray ionization mass spectrometry method for the quantification of perindopril and its main metabolite in human plasma. Georgakakou S; Kazanis M; Panderi I Anal Bioanal Chem; 2010 Jul; 397(6):2161-70. PubMed ID: 20195579 [TBL] [Abstract][Full Text] [Related]
17. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement. Jackson B; Cubela RB; Johnston CI J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609 [TBL] [Abstract][Full Text] [Related]
19. Effects of perindopril on angiotensin converting enzyme in tissues of the rat. Jackson B; Cubela RB; Johnston CI J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236 [TBL] [Abstract][Full Text] [Related]
20. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril. Jackson B; Cubela RB; Sakaguchi K; Johnston CI Endocrinology; 1988 Jul; 123(1):50-5. PubMed ID: 2838262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]